Ashland Q3 adjusted EBITDA up 5% to $139M; adjusted EPS $1.49 beats prior year $1.23

ASHLAND INC.

2024-Q3 EPS reported $3.01 revenue$1,591,000,000

Sales $544M flat YoY; adjusted EBITDA $139M (+5%) on volume gains, favorable mix, and deflationary raw materials.
GAAP continuing ops EPS $0.60 vs $0.79; adjusted EPS excl. intangibles amortization $1.49 vs $1.23.
Repurchased 1.3M shares during Q3; $770M remaining under authorization.
Operating cash flow $128M; ongoing free cash flow $112M, up from $97M in prior-year quarter.
Personal Care and Specialty Additives volume growth offset by weaker Life Sciences; June softer than expected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.